Skip to main content

Market Overview

Why Tonix Pharma Is Trading Higher Today


Tonix Pharmaceuticals (NASDAQ: TNXP) shares are trading higher Thursday after the company announced a licensing agreement of its technology for a rare genetic eating disorder.

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is engaged in discovering, licensing, acquiring and developing drugs and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes biologics to prevent infectious diseases and small molecules and biologics to treat pain, psychiatric and addiction conditions.

See also: Best Pharma ETFs

Tonix Pharmaceuticals was trading up 18.41% at $1.93. The stock has a 52-week high of $2.46 and a 52-week low of 39 cents.


Related Articles (TNXP)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Small Cap

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at